CCS
AGEN

Crosspoint Capital Strategies’s Agenus AGEN Stock Holding History

Crosspoint Capital Strategies’s Portfolio AGEN Stock Details AGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10
Closed -$1K – 504
2014
Q1 		$1K Hold
10
– – ﹤0.01% 652
2013
Q4 		$1K Buy
+10
New +$515 ﹤0.01% 555

Other funds holding AGEN

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Crosspoint Capital Strategies's AGEN Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of Agenus (AGEN) in Q2 2014, closing a stake of 10 shares — an estimated $1K sold.

Crosspoint Capital Strategies first reported a position in AGEN in Q4 2013 and held it in 2 quarters. The position peaked at $1K in Q1 2014. 68 funds tracked by Wall St. Rank hold AGEN as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining Agenus position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 10 Agenus shares in Q2 2014, an estimated $1K.
  • Crosspoint Capital Strategies first reported a position in Agenus in Q4 2013 and held it in 2 quarters.
  • Crosspoint Capital Strategies's Agenus position peaked at $1K in Q1 2014.
  • 68 funds tracked by Wall St. Rank held Agenus as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.